WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing.

ABSTRACT:

Motivation

Copy number variations (CNVs) are a major source of genomic variability and are especially significant in cancer. Until recently microarray technologies have been used to characterize CNVs in genomes. However, advances in next-generation sequencing technology offer significant opportunities to deduce copy number directly from genome sequencing data. Unfortunately cancer genomes differ from normal genomes in several aspects that make them far less amenable to copy number detection. For example, cancer genomes are often aneuploid and an admixture of diploid/non-tumor cell fractions. Also patient-derived xenograft models can be laden with mouse contamination that strongly affects accurate assignment of copy number. Hence, there is a need to develop analytical tools that can

SUBMITTER: Holt C 

PROVIDER: S-EPMC3957071 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature